Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy

(2010) A. J. FREEMONT et al.   BRITISH JOURNAL OF DERMATOLOGY

Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis

(2010) B. J. Rabquer et al.   JOURNAL OF IMMUNOLOGY

Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion

(2009) Y Hou et al.   ANNALS OF THE RHEUMATIC DISEASES

Chemokine C–X–C motif receptor 6 contributes to cell migration during hypoxia

(2009) Sensen Lin et al.   CANCER LETTERS

Serum CXCL16 Concentrations Correlate with the Extent of Skin Sclerosis in Patients with Systemic Sclerosis

(2009) K. YANABA et al.   JOURNAL OF RHEUMATOLOGY

Scleroderma

(2009) Armando Gabrielli et al.   NEW ENGLAND JOURNAL OF MEDICINE

The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1

(2009) B. J. Rabquer et al.   RHEUMATOLOGY

Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis

(2009) Christian Beyer et al.   ARTHRITIS RESEARCH & THERAPY

Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium

(2008) Bradley J. Rabquer et al.   ARTHRITIS AND RHEUMATISM

The role of CXC chemokines and their receptors in cancer

(2008) Jo Vandercappellen et al.   CANCER LETTERS

Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production

(2008) S. Ahmed et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CXCL10 ( ) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study

(2007) A. Antonelli et al.   RHEUMATOLOGY